Bluejay Diagnostics, Inc. (BJDX)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Indranil Dey | Principal Financial, Accounting & Executive Officer, President, CEO and Director | 292.15k | -- | 1963 |
| Dr. Jason Cook | Chief Technology Officer | 240.29k | -- | 1982 |
| Mr. Les DeLuca | Vice President of Operations | -- | -- | -- |
| Mr. Kevin Vance | Chief Commercial Officer | -- | -- | 1958 |
| Mark W. Feinberg | Chief Medical Advisor | -- | -- | -- |
| Dr. Mark W. Feinberg M.D. | Chief Medical Advisor | -- | -- | -- |
Bluejay Diagnostics, Inc.
- Sector:?
- Healthcare
- Industry:? Medical Devices
- Full Time Employees:?
- 10
Description
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available